(MYL) |
| 0 (0%) 10-12 00:56 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Tue, 15 Sep 2026
Munich Young Leaders Annual Meeting - Münchner Sicherheitskonferenz
Mon, 07 Sep 2026
MYL Kozhikode district conference from September 9 to 11 - The Hindu
Mon, 07 Sep 2026
Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema - Eyewire+
Wed, 19 Aug 2026
Honderd Myl Per Uur - Henri Alant (Official Lyric Music Video) - YouTube
Tue, 14 Jul 2026
Biocon’s Yesafili gains fresh clinical backing - Indian Pharma Post
Thu, 09 Jul 2026
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept) - BioSpace
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
